Luke Helminiak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luke Helminiak has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bennett Shaw
UCLA David Geffen School of Medicine
1 shared publication Colette J. Matysiak Match
UCLA David Geffen School of Medicine
1 shared publication- Daniel Z. Uslan
UCLA David Geffen School of Medicine
1 shared publication - Evann E. Hilt
Department of Laboratory Medicine and Pathology, University of Minnesota
1 shared publication - Kavitha K. Prabaker
UCLA David Geffen School of Medicine
1 shared publication - Mario Jaramillo
UCLA David Geffen School of Medicine
1 shared publication
Latest Publications
- Open Access
- 12 November 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e360
Homogeneous antimicrobial resistance gene profiles despite phylogenetic diversity in carbapenem-resistant Acinetobacter baumannii : a single health system study in Los Angeles, 2019–2026
This study characterizes the clinical, genomic, and antimicrobial resistance profiles of thirty carbapenem-resistant A. baumannii isolates recovered from patients in a multi-hospital health system. Medical record review identified high proportion of patients with invasive devices, long-term facility exposure, and combination therapy. Genomic analysis demonstrated genomic diversity but homogeneous antimicrobial resistance profiles.
- 12 November 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e360
Open AccessHomogeneous antimicrobial resistance gene profiles despite phylogenetic diversity in carbapenem-resistant Acinetobacter baumannii : a single health system study in Los Angeles, 2019–2026
This study characterizes the clinical, genomic, and antimicrobial resistance profiles of thirty carbapenem-resistant A. baumannii isolates recovered from patients in a multi-hospital health system. Medical record review identified high proportion of patients with invasive devices, long-term facility exposure, and combination therapy. Genomic analysis demonstrated genomic diversity but homogeneous antimicrobial resistance profiles.
- Open Access
- 17 September 2026
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 57, 43-45
Microbe snapshot – Candida auris
- 17 September 2026
- Published by Elsevier in Clinical Microbiology Newsletter
- Vol. 57, 43-45
Open AccessMicrobe snapshot – Candida auris